Yersinia remodels epigenetic histone modifications in human macrophages

PLoS Pathog. 2021 Nov 18;17(11):e1010074. doi: 10.1371/journal.ppat.1010074. eCollection 2021 Nov.

Abstract

Various pathogens systematically reprogram gene expression in macrophages, but the underlying mechanisms are largely unknown. We investigated whether the enteropathogen Yersinia enterocolitica alters chromatin states to reprogram gene expression in primary human macrophages. Genome-wide chromatin immunoprecipitation (ChIP) seq analyses showed that pathogen-associated molecular patterns (PAMPs) induced up- or down-regulation of histone modifications (HMod) at approximately 14500 loci in promoters and enhancers. Effectors of Y. enterocolitica reorganized about half of these dynamic HMod, with the effector YopP being responsible for about half of these modulatory activities. The reorganized HMod were associated with genes involved in immune response and metabolism. Remarkably, the altered HMod also associated with 61% of all 534 known Rho GTPase pathway genes, revealing a new level in Rho GTPase regulation and a new aspect of bacterial pathogenicity. Changes in HMod were associated to varying degrees with corresponding gene expression, e. g. depending on chromatin localization and cooperation of the HMod. In summary, infection with Y. enterocolitica remodels HMod in human macrophages to modulate key gene expression programs of the innate immune response.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Epigenesis, Genetic*
  • Histone Code*
  • Humans
  • Immunity, Innate*
  • Macrophages / immunology
  • Macrophages / metabolism
  • Macrophages / microbiology*
  • Yersinia Infections / genetics
  • Yersinia Infections / immunology
  • Yersinia Infections / metabolism
  • Yersinia Infections / microbiology*
  • Yersinia enterocolitica / pathogenicity*
  • rho GTP-Binding Proteins / genetics
  • rho GTP-Binding Proteins / metabolism*

Substances

  • rho GTP-Binding Proteins

Grants and funding

The investigators IB, AG, TG, NF and MAe were supported by the research consortium EPILOG, funded by the Stiftung zur Förderung der wissenschaftlichen Forschung in Hamburg (LFF-FV44: EPILOG) https://h-w-s.org/. The investigators MS, JH, MR, LB and KR were supported by Universitätsklinikum Hamburg-Eppendorf https://www.uke.de. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.